Human monocytes subjected to ischaemia/reperfusion inhibit angiogenesis and wound healing in vitro
Lars HummitzschM. AlbrechtKarina ZittaKatharina HeßKerstin ParczanyRené RuschJochen CremerMarkus SteinfathAssad HaneyaFred FaendrichRouven Berndt
11
Citation
64
Reference
10
Related Paper
Citation Trend
Abstract:
Abstract Objectives The sequence of initial tissue ischaemia and consecutive blood flow restoration leads to ischaemia/reperfusion (I/R) injury, which is typically characterized by a specific inflammatory response. Migrating monocytes seem to mediate the immune response in ischaemic tissues and influence detrimental as well as regenerative effects during I/R injury. Materials and Methods To clarify the role of classical monocytes in I/R injury, isolated human monocytes were subjected to I/R in vitro (3 hours ischaemia followed by 24 hours of reperfusion). Cellular resilience, monocyte differentiation, cytokine secretion, as well as influence on endothelial tube formation, migration and cell recovery were investigated. Results We show that I/R supported an enhanced resilience of monocytes and induced intracellular phosphorylation of the prosurvival molecules Erk1/2 and Akt. FACS analysis showed no major alteration in monocyte subtype differentiation and surface marker expression under I/R. Further, our experiments revealed that I/R changes the cytokine secretion pattern, release of angiogenesis associated proteins and MMP‐9 activity in supernatants of monocytes exposed to I/R. Supernatants from monocytes subjected to I/R attenuated endothelial tube formation as indicator for angiogenesis as well as endothelial cell migration and recovery. Conclusion In summary, monocytes showed no significant change in cellular integrity and monocyte subtype after I/R. Functionally, monocytes might have a rather detrimental influence during the initial phase of I/R, suppressing endothelial cell migration and neoangiogenesis.Keywords:
Monocyte
This chapter contains sections titled: Introduction In vivo imaging of angiogenesis and microcirculation Chamber assays Physiological angiogenesis Tumour angiogenesis Angiogenesis in endometriosis Angiogenesis in wound and bone healing Angiogenesis in ischaemia and hypoxia Angiogenesis in transplantation Angiogenesis in biomaterial incorporation Angiogenesis in tissue engineering Conclusions and perspectives References
Angiogenin
Hypoxia
Cite
Citations (1)
To determine whether homocysteine induced endothelial damage through monocyte-endothelial interaction and to characterize both cell types in vitro.Radiomethods were performed on monocyte adhesion to/through endothelium and endothelial damage experiments.Homocysteine-treated endothelial cells increased monocyte adhesion and transmigration. Homocysteine-treated monocytes induced endothelial detachment, but this effect was blocked by catalase. These effects were increased with higher concentrations of homocysteine. Monocyte surface glycoprotein antibodies CD11b/CD18 and CD14 inhibited these processes.Homocysteine alters monocyte-endothelial interaction in vitro, eventually bringing about endothelial damage through release of H(2)O(2). These phenomena are mediated through monocyte surface glycoproteins CD11b/CD18 and CD14. Upregulation of these processes in vivo may contribute to acceleration of atherosclerosis in patients with elevated plasma homocysteine levels.
Monocyte
Endothelial Dysfunction
Cite
Citations (6)
Sprouting angiogenesis
Cite
Citations (0)
Angiogenesis, a formation of neovessels, is regulated by the local balance between angiogenesis stimulators and inhibitors. A number of such endogenous regulators of angiogenesis have been found in the body. Recently, vasohibin-1 (VASH1) was isolated as a negative feedback regulator of angiogenesis produced by endothelial cells (ECs) and subsequently vasohibin-2 (VASH2) as a homologue of VASH1. It was then explored that VASH1 is expressed in ECs to terminate angiogenesis, whereas VASH2 is expressed in cells other than ECs to promote angiogenesis in the mouse model of angiogenesis. This review will focus on the vasohibin family members, which are novel regulators of angiogenesis.
Angiogenesis inhibitor
Cite
Citations (101)
Angiogenesis is the process of new blood vessel growth and is a critical biological process under both physiologic and pathologic conditions. Angiogenesis can occur under physiologic conditions that include embryogenesis and the ovarian/menstrual cycle. In contrast, pathologic angiogenesis is associated with chronic inflammation/chronic fibroproliferative disorders and tumorigenesis of cancer. Similarly, aberrant angiogenesis associated with chronic inflammation/fibroproliferative disorders is analogous to neovascularization of tumorigenesis of cancer. Net angiogenesis is determined by a balance in the expression of angiogenic compared with angiostatic factors. CXC chemokines are heparin-binding proteins that display unique disparate roles in the regulation of angiogenesis. Based on their structure, CXC chemokines can be divided into two groups that either promote or inhibit angiogenesis, and they are therefore uniquely placed to regulate net angiogenesis in both physiologic and pathologic conditions.
Cite
Citations (0)
Angiogenesis inhibitor
Cite
Citations (26)
Angiogenesis is regulated by a local balance between the levels of endogenous stimulators and inhibitors of angiogenesis. Understanding of the mechanism of angiogenesis has advanced significantly since the discovery of two members of the family of angiogenesis stimulators, i.e., vascular endothelial growth factor family proteins and angiopoietins. These factors act on endothelial cells to stimulate angiogenesis. In contrast, most of angiogenesis inhibitors do not seem to have such characteristics. Very few genes encoding molecules that selectively inhibit angiogenesis have been discovered. This review will focus on our current understanding of endogenous inhibitors of angiogenesis.
Cite
Citations (41)
Chorioallantoic membrane
Cite
Citations (0)
Angiogenesis 为许多生理、病理学的过程是很重要的。然而， angiogenesis 的分子的机制是不清楚的。阐明 angiogenesis 并且到的分子的机制为 angiogenesis 依赖的疾病开发处理，建立是必要的一在 vitro angiogenesis 合适模型。在这研究，我们基于一台 microfluidic 设备在 vitro angiogenesis 模型创造了一篇小说。我们的模型提供一在里面为 endothelial 房间(EC ) 的象 vivo 一样微型环境文化和监视器到在他们在实时的微型环境的变化的 EC 的反应。为了为研究 angiogenesis， EC 增长上的 pro-angiogenic 因素的效果，迁居和像试管的结构形成评估这台 microfluidic 设备的潜力，被调查。我们的结果证明在 3D 矩阵的 EC 的增长率被 pro-angiogenic 因素显著地支持(随 59.12% 的增加) 。与 pro-angiogenic 因素坡度的刺激，方向性地从低集中移植进 Matrigel 到高集中并且因而的 EC 形成了多房间弦和像试管的结构。这些结果建议设备能为阐明提供一个合适的平台 angiogenesis 并且为为 angiogenesis 依赖的疾病屏蔽 pro-angiogenic 或 anti-angiogenic 药的机制。
Matrigel
Cite
Citations (8)
Preface The History and Development of Angiogenesis Research The Rho GTPases and Angiogenesis Nitric Oxide and Angiogenesis Hemostasis and Angiogenesis Pericytes and Angiogenesis New Proteins from Snake Venom: Attractive Tools for Studying Angiogenesis Calcium and Angiogenesis The Critical Role of Inflammatory Cell Infiltration in Tumour Angiogenesis: A Target for Anti-Tumour Drug Development? Contrast-Enhanced Dynamic Computed Tomography for the Prevalence of Tumour Angiogenesis in Lung Cancer: A Prospective Study Angiogenesis in Gynaecological Cancers Angiogenesis as Discriminating Aspect Between Melanoma and Uncertain Melanocytic Lesions: An Immunohistochemical Study The Role of the Nitric Oxide Pathway in Controlling Angiogenesis in Head and Neck Cancer Angiogenesis and Anti-Angioenesis in Neoplastic and Non-Neoplastic Diseases Immunobiology and Regulatory Mechanisms of the Expression of Angiogenic and Angiostatic Factors in Arthritis Inflammation Index.
Cite
Citations (6)